These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 879100)

  • 1. Antithrombin III and Factor VIII in patients with neoplasms.
    Losito R; Beaudry P; Valderrama JC; Cousineau L; Longpré B
    Am J Clin Pathol; 1977 Aug; 68(2):258-62. PubMed ID: 879100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W; Rothwangl HJ
    Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
    Sudusinghe D; Riddell A; Gandhi T; Chowdary P; Davenport A
    Hemodial Int; 2023 Jan; 27(1):38-44. PubMed ID: 36081392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III and factor VIII in patients with neoplasms.
    Bick RL
    Am J Clin Pathol; 1978 Feb; 69(2):194-5. PubMed ID: 629228
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercoagulability in patients with peripheral vascular disease.
    Collins GJ; Heymann RL; Zajtchuk R
    Am J Surg; 1975 Jul; 130(1):2-6. PubMed ID: 1155713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercoagulability and hypofibrinolysis in sickle-cell disease.
    Stathakis NE; Papayannis AG; Papayatos H; Scliros P; Gardikas C
    Blut; 1975 Dec; 31(6):355-60. PubMed ID: 1203541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
    Matsumoto T; Shima M; Takeyama M; Yoshida K; Tanaka I; Sakurai Y; Giles AR; Yoshioka A
    J Thromb Haemost; 2006 Feb; 4(2):377-84. PubMed ID: 16420569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
    Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
    Virtanen L; Salmela B; Leinonen J; Lemponen M; Huhtala J; Joutsi-Korhonen L; Lassila R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):597-603. PubMed ID: 24732174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.
    Jha NK; Shestopal SA; Gourley MJ; Woodle SA; Liang Y; Sarafanov AG; Weinstein M; Ovanesov MV
    Haemophilia; 2016 Sep; 22(5):780-9. PubMed ID: 27038076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII concentration is greater in female than male patients with HIV infection.
    Abdollahi A; Morteza A; Khalilzadeh O; Ahmadzadeh A
    Int J Hematol; 2011 Jan; 93(1):53-8. PubMed ID: 21161619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A.
    Ninivaggi M; Dargaud Y; van Oerle R; de Laat B; Hemker HC; Lindhout T
    J Thromb Haemost; 2011 Aug; 9(8):1549-55. PubMed ID: 21605333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mild factor VIII Deficiency by thrombokinetics.
    Natelson EA; Shapiro D; Smith DF
    Am J Clin Pathol; 1975 Jul; 64(1):95-100. PubMed ID: 1155379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
    Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
    Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.
    Weinstein MJ; Chute LE; Schmitt GW; Hamburger RH; Bauer KA; Troll JH; Janson P; Deykin D
    J Clin Invest; 1985 Oct; 76(4):1406-11. PubMed ID: 3932466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of coagulation factors on extrinsic thrombin generation.
    Stief TW; Wieczerzak A; Renz H
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):105-12. PubMed ID: 17287625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.